One of the key elements to successful implementation of this program is the continuity of follow ups and the patient’s adherence to their medication regime. This can only be achieved if the patient-clinician is a long-term relationship at a centralised location. With employers now becoming increasingly mindful of their staff’s health, Panahf realised an opportunity to expand the reach of the program. PANAHF approached companies that employ a large number of manual labourers to allow us to conduct the screenings and follow ups at their places of work.
Once consent is obtained from the management and a date is set, a certified Clinical Officer(s) reports to the organisation over a period of days depending on the employee base and conducts the screening and required management plans with monthly follow ups where required. Medications are then delivered on a name basis to the organisation. Some organisations have committed to cater for the cost of medication for their employees.
So far six medium and large organisations have committed to the program with dates scheduled. With just these six organisations, screened numbers will be boosted by 3000. Talks are underway with several other organisations.
1388 | TOTAL NUMBER SCREENED |
8.28% | NUMBER (%) KNOWN HYPERTENSION |
3.31% | NUMBER (%) KNOWN DIABETES |
N/A | NUMBER (%) KNOWN HYPERTENSION |
N/A | NUMBER (%) NEW DIABETES |
N/A | PREVALENCE |
7.42% | DIABETES |
18.15% | HYPERTENSION |